---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-004477"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2023-06-28T23:59:59+00:00"
generated_at: "2026-06-13T15:52:39.824498+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical reports FY2023 cash $14.5M, operating expenses $12.47M; advances Hemopurifier trials

## Summary
- Cash balance $14.5M at March 31, 2023; operating expenses $12.47M, up $1.76M from $10.71M in FY2022.
- COVID-19 ICU trial in India: one patient treated; second hospital (MAMC) got ethics approval in May 2023.
- Oncology clinical trial planned in Australia: safety/feasibility/dose-finding in solid tumors failing anti-PD-1 antibodies.
- New organ transplant initiative: testing Hemopurifier in machine perfusion to remove viruses/exosomes from harvested organs.

## SEC filing metadata
- accession: 0001683168-23-004477
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2023-06-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316823004477/0001683168-23-004477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316823004477/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-004477
- JSON: https://secwatch.observer/filing/0001683168-23-004477.json
- Plain text: https://secwatch.observer/filing/0001683168-23-004477.txt

## Key facts
- Earnings Releases
  AETHLON MEDICAL INC reported financial results for fiscal year ended March 31, 2023.
  - Period: fiscal year ended March 31, 2023
  - Result: reported results
  source text: issued a press release announcing its financial results for the fiscal year ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823004477/0001683168-23-004477-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.